Results 71 to 80 of about 2,722,809 (208)
Drug-resistant tuberculosis in the 1990s [PDF]
European Respiratory Journal, 1995 There has been an upsurge of tuberculosis in many parts of the world in the past decade. The high rates of drug-resistant tuberculosis currently reported in many countries are alarming. The most catastrophic phenomenon is the emergence of multidrug-resistant strains of Mycobacterium tuberculosis.W W, Yew, C H, Chauopenaire +2 more sourcesNegligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy [PDF]
, 2016 Post-exposure prophylaxis (PEP) for leprosy is administered as one single dose of rifampicin (SDR) to the contacts of newly diagnosed leprosy patients. SDR reduces the risk of developing leprosy among contacts by around 60 % in the first 2-3 years after ...Richard Anthony, Steinmann, P. (Peter), Mieras, Liesbeth, Bratschi, M W, Jan Hendrik Richardus, Kasang, C. (Christa), Arielle Cavaliero, Mieras, L. (Liesbeth), Lee Reichman, Jacques van den Broek, Cavaliero, A. (Arielle), Christa Kasang, Yew, W.W. (Wing Wai), Anthony, R, van Brakel, Wim, Reichman, L, Emmanuelle Cambau, Anthony, Richard, Steinmann, Peter, Perera, G, Saunderson, P. (Paul), Saunderson, Paul, Cavaliero, Arielle, Saunderson, P, Richardus, Jan hendrik; id_orcid, Kasang, Christa, van den Broek, Jacques, Kasang, C, Richardus, J.H. (Jan Hendrik), Cavaliero, A, Cambau, E. (Emmanuelle), Peter Steinmann, Anthony, R. (Richard), Yew, W W, Reichman, L. (Lee), Mieras, L, Yew, Wing Wai, Perera, G. (Geethal), Richardus, Jan Hendrik, Wim van Brakel, Brakel, W.H. (Wim) van, Bratschi, M.W. (Martin W.), Paul Saunderson, van Brakel, W, Cambau, E, Reichman, Lee, van den Broek, J, Bratschi, Martin W., Steinmann, P, Cambau, Emmanuelle, Geethal Perera, Wing Wai Yew, van den Broek, J. (Jacques), Perera, Geethal, Liesbeth Mieras, Martin W. Bratschi +55 morecore +2 more sourcesExtensively drug resistant tuberculosis [PDF]
BMJ, 2006 Tuberculosis outbreaks in the developed world are newsworthy. However in the developing world where deaths from tuberculosis are common it takes something exceptional for an outbreak to attract much attention. In response to a recent report at the 16th international AIDS conference and to increasing South African media reports the World Health ...Lawn, Stephen D, Wilkinson, Robertopenaire +3 more sourcesLabel-Free Quantitative Proteomics Identifies Novel Plasma Biomarkers for Distinguishing Pulmonary Tuberculosis and Latent Infection
Frontiers in Microbiology, 2018 The lack of effective differential diagnostic methods for active tuberculosis (TB) and latent infection (LTBI) is still an obstacle for TB control. Furthermore, the molecular mechanism behind the progression from LTBI to active TB has been not elucidated.Huishan Sun, Liping Pan, Hongyan Jia, Zhiguo Zhang, Mengqiu Gao, Mailing Huang, Jinghui Wang, Qi Sun, Rongrong Wei, Boping Du, Aiying Xing, Zongde Zhang +11 moredoaj +1 more sourceA Prospective Assessment of Therapeutic Efficacy and Immune Effects of Levofloxacin and Ofloxacin in Multiple-Drug Resistant Tuberculosis
, 2021 Background: Multi-drug resistant tuberculosis impairing the effectiveness of standard treatments may contribute to increased mortality. High failure and relapse rates are recorded when standard regimens are used for multi-drug resistant ...Karagoz, Turan, Kiran, Bayram, Izzettin, Fikret Vehbi, Clark, Philip Martin, Apikoglu-Rabus, Sule +4 morecore Isoniazid preventive therapy and risk for resistant tuberculosis. [PDF]
, 2006 In the context of tuberculosis (TB) resurgence, isoniazid preventive therapy (IPT) is increasingly promoted, but concerns about the risk for development of isoniazid-resistant tuberculosis may hinder its widespread implementation.Grant, Alison D, Balcells, Maria Elvira, Thomas, Sara L, Peter Godfrey-Faussett, Maria Elvira Balcells, Godfrey-Faussett, Peter, Sara L. Thomas, Alison D. Grant +7 morecore +1 more sourceIdentification of novel Imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB [PDF]
, 2012 Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB ...Fernández, Raquel, Nicholas J Loman, Besra, Gurdyal S., Ballell, L, Raquel Fernández, Pallen, Mark J., Abrahams, Katherine A, Loman, Nicholas J., Abrahams, Katherine A., Spivey, VL, Constantinidou Chrystala, Mark J Pallen, Remuiñán, Modesto J, Cox, Jonathan A G, Abrahams Katherine A., Loman, Nicholas J, Carlos Alemparte, Lluis Ballell, Cox Jonathan A. G., Loman, NJ, Besra, GS, Constantinidou, Chrystala, Alemparte Carlos, Pallen, Mark J, Besra, Gurdyal S; id_orcid, Abrahams, KA, Remuiñán, Modesto J., Besra Gurdyal S., Remuiñán Modesto J., Vickey L Spivey, Chrystala Constantinidou, Pallen, MJ, Barros, D, Loman Nicholas J., Ballell, Lluis, Fernández, R, Alemparte, Carlos, Cox, Jonathan A. G., Cox, JA, Modesto J Remuiñán, Barros David, Jonathan A G Cox, Gurdyal S Besra, Fernández Raquel, Spivey, Vickey L., David Barros, Constantinidou, C, Ballell Lluis, Spivey Vickey L., Barros, David, Spivey, Vickey L, Pallen Mark J., Remuiñán, MJ, Alemparte, C, Katherine A Abrahams +54 morecore +2 more sourcesThe challenge of drug-resistant tuberculosis
Cleveland Clinic Journal of Medicine, 1994 CLINICAL ISSUES: After declining for decades, the incidence of tuberculosis is again increasing, and strains resistant to multiple drugs are appearing. The greatest increases in infection have been in blacks and Hispanics. The disease is most aggressive in patients infected with human immunodeficiency virus and in patients receiving immunosuppressive ...openaire +2 more sourcesTetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3 [PDF]
, 2013 Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB.Nalini Mehta, Joaquín Rullás, Minick, Douglas J, María Martínez-Hoyos, Pallen, Mark J., Rebollo-López María José, Sousa, Verónica, Modesto J. Remuiñán (291058), Chrystala Constantinidou (161352), Johnson Afari, Pérez-Herrán Esther, Jorge Esquivias (403585), Jiménez, Elena, Jiménez Elena, Dow, David J, Constantinidou Chrystala, Fátima Ortega-Muro, Remuiñán, Modesto J, Esquivias Jorge, Fátima Ortega-Muro (403586), Mendoza-Losana, Alfonso, Pallen, Mark J, Lluís Ballell (2196634), Rullás, Joaquín, Besra, Gurdyal S; id_orcid, Vickey L Spivey, María Teresa Fraile-Gabaldón, Carolina González, Sousa Verónica, González, Carolina, Mónica Cacho, Ballell, Lluís, Martínez-Hoyos María, Elena Jiménez (47475), Carolina González (321712), María José Rebollo-López, Pérez-Herrán, Esther, Johnson Afari (403583), Esquivias, Jorge, Spivey, Vickey L., Nicholas J. Loman (126279), Verónica Sousa, Mehta, Nalini, Rebollo-López, María José, Cacho Mónica, Angulo-Barturen, Iñigo, Spivey Vickey L., Barros, David, Vickey L. Spivey (291055), Spivey, Vickey L, Esther Pérez-Herrán, Minick Douglas J., Alfonso Mendoza-Losana (403592), Cacho, Mónica, Nicholas J Loman, Lluís Ballell, Alfonso Mendoza-Losana, Besra, Gurdyal S., Dow David J., Loman, Nicholas J., Mehta Nalini, David J. Dow (403582), Afari, Johnson, Nicholas Cammack (403593), Rullás Joaquín, Iñigo Angulo-Barturen, Esther Pérez-Herrán (403580), Mark J Pallen, Loman, Nicholas J, Carlos Alemparte, Constantinidou, Chrystala, Alemparte Carlos, Fraile-Gabaldón, María Teresa, David J Dow, Douglas J Minick, Remuiñán, Modesto J., Besra Gurdyal S., Gurdyal S. Besra (37660), Remuiñán Modesto J., Chrystala Constantinidou, Mark J. Pallen (8904), Cammack, Nicholas, Ortega-Muro, Fátima, Mendoza-Losana Alfonso, Joaquín Rullás (5654542), Dow, David J., Angulo-Barturen Iñigo, Loman Nicholas J., Nalini Mehta (403584), Alemparte, Carlos, Minick, Douglas J., David Barros (291059), María Teresa Fraile-Gabaldón (403587), Modesto J Remuiñán, Barros David, María Martínez-Hoyos (403581), Mónica Cacho (403589), Cammack Nicholas, Ortega-Muro Fátima, Elena Jiménez, Carlos Alemparte (291057), Afari Johnson, Gurdyal S Besra, Fraile-Gabaldón María Teresa, Martínez-Hoyos, María, David Barros, Iñigo Angulo-Barturen (47469), Ballell Lluís, González Carolina, Douglas J. Minick (403588), Jorge Esquivias, María José Rebollo-López (403590), Pallen Mark J., Nicholas Cammack, Verónica Sousa (403591) +114 morecore +1 more source
